Insight

Oct 19, 2024, 09:50

Updates on the GI and Neuroendocrine Tumors working group

Immune Oncology Research Institute shared a post on LinkedIn:

“During its first year, the GI and Neuroendocrine Tumors Working Group of the Immune Oncology Research Institute held 26 meetings, reviewing 98 cases. Led by Professor Philip Agop Philip, with Dr. Lilit Harutyunyan as co-chair and Mariam Sargsyan as coordinator, the group meets biweekly to discuss complex cases from Armenia’s major cancer centers: Mikaelyan Institute of Surgery, Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia Hematology and Oncology Center, and the National Center of Oncology.

These meetings improve treatment strategies and patient outcomes by fostering multidisciplinary collaboration and tailored care for gastrointestinal and neuroendocrine tumor cases.

For more information.”

Immune Oncology Research Institute (IMMONC), established in 2022, is a non-profit, independent, patient-centered research institute. The mission of IMMONC is to advance the cancer knowledge and care through breakthrough scientific research, to integrate innovative immune-oncology therapies into the clinical practice for different types of cancers, to generate and collect clinical data for the identification of new therapeutic targets, developing predictive models and optimizing patient outcomes, to increase the availability and accessibility of those discoveries for the cancer patients, to create a world-class professional environment, to attract the brightest minds in cancer field and to train the next generation researchers.